***New analysis / price targets given the recent 1/10 split:**
The historical simple moving average (SMA) I've selected for Angi (formerly Angie's List Inc)
ANGI is starting to enter stock price. This often means a directional change in price: up in this case. The price drop after the last earnings, I believe, was an algorithmic move for price entry/further consolidation. If true, the two large gaps above may be filled in the future. 70M float, 20% short interest...
Fundamentally, Angi maintains a solid financial foundation with $395 million in cash and cash equivalents. The company's free cash flow increased $29.2 million to $78.4 million for the first nine months of 2024, demonstrating strong cash generation capabilities. The company's transition to a consumer choice model, already successful in its European operations, positions Angi to capture greater market share. Despite revenue headwinds, Angi demonstrates robust financial health with operating income increasing to $7.8 million in third-quarter 2024, a significant improvement from the previous year. The company's adjusted EBITDA grew 27% to $35.4 million, while year-to-date operating income reached $20 million with adjusted EBITDA rising 47% to $114 million, showcasing effective cost management and improving operational efficiency.
Thus at $20.05,ANGI is in a personal buy zone (this is the adjusted price from the original entry in December 2024 at $2.00, post 1/10 split). There absolutely could be more downside aside for this stock, but it is a personal buy and hold for the coming years (unless fundamentals drastically change).
Targets:
The historical simple moving average (SMA) I've selected for Angi (formerly Angie's List Inc)
ANGI is starting to enter stock price. This often means a directional change in price: up in this case. The price drop after the last earnings, I believe, was an algorithmic move for price entry/further consolidation. If true, the two large gaps above may be filled in the future. 70M float, 20% short interest...Fundamentally, Angi maintains a solid financial foundation with $395 million in cash and cash equivalents. The company's free cash flow increased $29.2 million to $78.4 million for the first nine months of 2024, demonstrating strong cash generation capabilities. The company's transition to a consumer choice model, already successful in its European operations, positions Angi to capture greater market share. Despite revenue headwinds, Angi demonstrates robust financial health with operating income increasing to $7.8 million in third-quarter 2024, a significant improvement from the previous year. The company's adjusted EBITDA grew 27% to $35.4 million, while year-to-date operating income reached $20 million with adjusted EBITDA rising 47% to $114 million, showcasing effective cost management and improving operational efficiency.
Thus at $20.05,
ANGI is in a personal buy zone (this is the adjusted price from the original entry in December 2024 at $2.00, post 1/10 split). There absolutely could be more downside aside for this stock, but it is a personal buy and hold for the coming years (unless fundamentals drastically change). Targets:
- $22.50
- $25.00
- $30.00
- $37.00
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.